Madrid / MHLW / Stockholm / Washington / Buenos Aires / Shanghai / Medicine / Rome / Welfare / Brussels / /
Company
BioMarin Pharmaceutical Inc. / Public Interest Corporation / Takeda Pharmaceutical Company Limited / Shire Pharmaceuticals / Congress Corporation / GlaxoSmithKline / Pfizer Japan Inc. / Eisai Co. Ltd. / Gador SA / JR East Building Co. Ltd. / Genzyme Corporation / Astellas Pharma Inc. / ICORD 2012 Report 7th ICORD International / PRIP Tokyo / /
Continent
America / Europe / Asia / North America / /
Country
Netherlands / Bulgaria / Netherland / France / Japan / Brazil / Canada / Australia / Korea / United Kingdom / China / Taiwan / Italy / Sweden / New Zealand / Belgium / Russia / United States / Nigeria / Singapore / Argentina / Spain / /
Currency
EUR / JPY / /
Event
FDA Phase / Natural Disaster / /
Facility
University Hospital Gasthuisberg / Tsinghua University / University of Western Australia / University of Tokyo / National Institute of Biomedical Innovation / Komaba Research Campus / Convention Hall / National Institute of Public Health / Karolinska Institute / International University of Health / University Research Center / /
IndustryTerm
approaches and tools / medicinal products / Treatment of Special Chronic Diseases / treatment of rare and intractable diseases / pharmaceuticals / therapy for Gaucher's disease / pediatric applications / pharmaceutical / social security systems / treatment protocols / health-insurance treatment / /
National Institute of Public Health / Medical Devices Agency / Health Policy Bureau / Health Policy Bureau Research and Development Division / University of Tokyo / Food Safety Bureau Evaluation and Licensing Division / Takeshi Nagao Intractable Diseases Research Foundation / FDA / European Union / Tokyo University Research Center for Advance Science and Technology Sponsors / Ministry of Health / Committee for Orphan Medicinal Products / Kato Memorial Bioscience Foundation / Tsinghua University / National Institute of Biomedical Innovation / Science Council of Japan / Geiser Foundation / Japan Patients Association Cosponsors / Department of Pediatrics / Karolinska Institute / University of Western Australia / Health Service Bureau Disease Control Division / Congress / Incorporated Administrative Agency / Graduate School / ICORD council / Ehime University Graduate School / European Medicines Agency / Terumo Life Science Foundation / Uehara Memorial Life Science Foundation / office of Orphan Products Development / Food Drug Administration / School of Paediatrics and Child Health / Japan Pharmaceutical Manufacturers Association / International University of Health and Welfare / /
Person
Agnes / Kenichi Tamiya / Naoko Yamamoto / Wang Cheng-guang / Pediatric Hemato-Oncology / Marc Dunoyer / Jan-Inge Henter / Jack Goldblatt / Emilio Roldán / Eiichi Ishii / Tomoko Kodama / Stefaan van Gool / Junji Annen / Domenica Taruscio / Howard Yuwen / Ichiro Kanazawa / Takeshi Nagao Intractable / Debra Lewis / /
Position
President / Head / last speaker / Deputy Director / Research and Development Division / Acting Director / Professor / Director / Disease Control Division / Senior Director Regulatory Affairs / Global head / Director Genetic Services & Familial Cancer Program / Chair / Conference Chair / Head of Human Medicines Special Areas / Director / Disease Control Division / Deputy Director / Research and Development Division / /
Microsoft Word - ICORD2012 Report